At this point, employers may be intimately familiar with many of the provisions of the Affordable Care Act - coverage until age 26, no exclusions for pre-existing conditions and others. But one clause that may have escaped the attention of benefit managers relates to experimental treatments and medications - if you weren't covering clinical trials, odds are you might have to now.
Starting next year, the health care reform act holds that a "qualified individual" cannot be denied coverage by a plan for "related services" from an approved clinical trial. While that by itself may not mean deep changes for most employer-sponsored health care plans, many of those medical studies say they will cover related expenses that aren't already taken care of by existing insurance - a convergence-of-care issue for even well-designed plans.
Register or login for access to this item and much more
All Employee Benefit News content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access